
|Slideshows|February 28, 2018
Medical News Quiz: Opioids, Concussion, Drug Safety, Digital Health
Author(s)Veronica Hackenthal, MD
Clinicians should use caution when prescribing this medication in patients with heart disease because of risk of severe adverse effects and even death. Test your skills in this FDA quiz.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Efgartigimod Effective in Seronegative gMG, Obexelimab Meets Primary End Point, FDA Accepts NDA for Tau Tracer MK-6240
2
Newly Unveiled EPIC Trial Pins Myasthenia Gravis Medications Nipocalimab Against Efgartigimod for Efficacy
3
Efgartigimod Treatment for CIDP Leads to Increased Spending, Study Shows
4
AI in MS: IJMSC Survey Results
5





























